Related Experiment Video
Updated: Mar 14, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
Dehomocysteinylation is catalysed by the sirtuin-2-like bacterial lysine deacetylase CobB
Xin-Yu Mei1,2, Xia-Di He1, Lei Huang1
1School of Life Sciences, Fudan University, Shanghai, China.
Insights
Elevated homocysteine (Hcy) is linked to diseases. This study reveals dehomocysteinylation is spontaneous and inhibited by blocking -SH groups. CobB is identified as the first enzyme to remove Hcy from proteins.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Hyperhomocysteinemia (elevated blood homocysteine) is an independent risk factor for cardiovascular diseases, neurodegenerative diseases, and birth defects.
- Protein N-homocysteinylation is a key mechanism contributing to hyperhomocysteinemia, but dehomocysteinylation processes and enzymes remain largely unknown.
Purpose of the Study:
- To investigate the mechanisms and regulation of dehomocysteinylation.
- To identify enzymes involved in the removal of homocysteine from proteins.
Main Methods:
- Studied the spontaneous dehomocysteinylation reaction.
- Investigated the role of -SH groups in the reaction.
- Utilized in vitro and in vivo assays to assess the enzymatic activity of CobB.
Main Results:
- Dehomocysteinylation is a spontaneous reaction inhibited by blocking -SH groups, crucial for non-enzymatic removal.
- CobB, a bacterial lysine deacetylase, was identified as catalyzing lysine dehomocysteinylation both in vitro and in vivo.
- CobB is the first identified prokaryotic enzyme responsible for dehomocysteinylation.
Conclusions:
- This study elucidates the spontaneous nature of dehomocysteinylation and the critical role of -SH groups.
- Identifies CobB as the first prokaryotic dehomocysteinylation enzyme, offering insights into homocysteine removal from proteins.
- Provides potential targets for developing methods to identify N-homocysteine proteins.
Abstract:
Hyperhomocysteinemia, which is characterized by elevated blood levels of the non-protein amino acid homocysteine (Hcy), is an independent risk factor for many diseases, including cardiovascular diseases, neurodegenerative diseases and birth defects. The incorporation of homocysteine into proteins, known as protein N-homocysteinylation, has been considered a major mechanism that contributes to hyperhomocysteinemia. However, the process of dehomocysteinylation, the N-homocysteinylation substrates and the regulatory enzyme(s) remain largely unknown. In this study, we observed that the dehomocysteinylation reaction is a spontaneous process that can be inhibited by blocking -SH groups, which have been demonstrated to be critical for non-enzymatic dehomocysteinylation reactions. We also report that CobB, a known Sir2-like bacterial lysine deacetylase, catalyzes lysine dehomocysteinylation reactions both in vitro and in vivo. Our work provides insight into how this non-enzymatic modification might be removed from affected proteins, supplies potential targets for developing identification methods for N-homocysteine proteins, and identifies CobB as the first prokaryotic dehomocysteinylation enzyme.
More Related Videos
Related Concept Videos
Sulfur Assimilation
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Amino Acid Catabolism
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...

